At the American College of Cardiology 2025 Annual Scientific Session, John W. Ostrominski, MD, of Brigham and Women’s Hospital, dives into the nuanced safety profile of finerenone for high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback